Adomeglivant


CAS No. : 1488363-78-5

(Synonyms: LY2409021)

1488363-78-5
Price and Availability of CAS No. : 1488363-78-5
Size Price Stock
5mg $90 In-stock
10mg $150 In-stock
25mg $250 In-stock
50mg $450 In-stock
100mg $750 In-stock
200 mg Get quote
500 mg Get quote
We match the lowest price on market.

We offer a substantial discount on larger orders, please inquire via [email protected]

or Fax: (86)21-58955996

Inquiry for price and availability only. Please place your order via our email or fax.

Cat. No. : HY-19904
M.Wt: 555.63
Formula: C32H36F3NO4
Purity: >98 %
Solubility: DMSO : ≥ 100 mg/mL
Introduction of 1488363-78-5 :

Adomeglivant (LY2409021) is a potent, selective glucagon receptor (GluR) allosteric antagonist. Adomeglivant is widely used in the research for type 2 diabetes mellitus[1][2][3]. IC50 & Target: GluR[1][2] In Vitro: Adomeglivant dose-dependently blocks glucagon-induced the raise levels of cAMP in HEK293-GluR cells[2].
Adomeglivant fails to block cAMP-elevating actions of adenosine[2].
Adomeglivant exhibits high selectivity for family B GPCRs, and specifically interacts with a conserved binding motif within the GluR, GLP-1R, and GIP-R[2].
In Vivo: Adomeglivant (5 mg/kg; i.p.) completely abolishes the hyperglycaemic action of CNO (clozapine-N-oxide) in Avpires-Cre+ mice. (CNO is a specific, pharmacologically inert agonist for hM3Dq-induced membrane depolarisation and increased the firing rate in hM3Dq-expressing arginine-vasopressin (AVP) neurons.)[3]

Your information is safe with us.